Notice for mavorixafor (Norgine Pty Ltd)
Active ingredients
mavorixafor
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
capsule
Indication
For the treatment of WHIM syndrome
Therapeutic area
Immunology